Tole, Mateo
LaBedz, Stephanie
Feinstein, Douglas L.
Rubinstein, Israel
Funding for this research was provided by:
National Institutes of Health (U01 NS083457)
National Institutes of Health (U01 NS083457-S1)
Article History
Received: 9 January 2019
Accepted: 8 April 2019
First Online: 19 April 2019
Compliance with Ethical Standards
:
: Drs. Rubinstein and Feinstein are co-founders of EnSol Therapeutics, LLC.
: This article does not contain any studies with human participants performed by any of the authors.